387 related articles for article (PubMed ID: 20166926)
21. Functional selectivity in cannabinoid signaling.
Varga EV; Georgieva T; Tumati S; Alves I; Salamon Z; Tollin G; Yamamura HI; Roeske WR
Curr Mol Pharmacol; 2008 Nov; 1(3):273-84. PubMed ID: 20021440
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor interacting protein suppresses agonist-driven CB
Blume LC; Leone-Kabler S; Luessen DJ; Marrs GS; Lyons E; Bass CE; Chen R; Selley DE; Howlett AC
J Neurochem; 2016 Nov; 139(3):396-407. PubMed ID: 27513693
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.
De Petrocellis L; Marini P; Matias I; Moriello AS; Starowicz K; Cristino L; Nigam S; Di Marzo V
Exp Cell Res; 2007 Aug; 313(14):2993-3004. PubMed ID: 17585904
[TBL] [Abstract][Full Text] [Related]
24. Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors.
Hudson BD; Hébert TE; Kelly ME
Br J Pharmacol; 2010 Jun; 160(3):627-42. PubMed ID: 20590567
[TBL] [Abstract][Full Text] [Related]
25. Signal transduction via cannabinoid receptors.
Dalton GD; Bass CE; Van Horn CG; Howlett AC
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):422-31. PubMed ID: 19839935
[TBL] [Abstract][Full Text] [Related]
26. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
Soethoudt M; van Gils N; van der Stelt M; Heitman LH
Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
[TBL] [Abstract][Full Text] [Related]
27. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
28. Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.
Turu G; Várnai P; Gyombolai P; Szidonya L; Offertaler L; Bagdy G; Kunos G; Hunyady L
J Biol Chem; 2009 Jun; 284(25):16914-16921. PubMed ID: 19357084
[TBL] [Abstract][Full Text] [Related]
29. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1.
Petgrave M; Ramgoolam SD; Ganesan A
J Chem Inf Model; 2024 Jan; 64(2):499-517. PubMed ID: 38159053
[TBL] [Abstract][Full Text] [Related]
31. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.
Sánchez C; Rueda D; Ségui B; Galve-Roperh I; Levade T; Guzmán M
Mol Pharmacol; 2001 May; 59(5):955-9. PubMed ID: 11306675
[TBL] [Abstract][Full Text] [Related]
32. A cannabinoid link between mitochondria and memory.
Hebert-Chatelain E; Desprez T; Serrat R; Bellocchio L; Soria-Gomez E; Busquets-Garcia A; Pagano Zottola AC; Delamarre A; Cannich A; Vincent P; Varilh M; Robin LM; Terral G; García-Fernández MD; Colavita M; Mazier W; Drago F; Puente N; Reguero L; Elezgarai I; Dupuy JW; Cota D; Lopez-Rodriguez ML; Barreda-Gómez G; Massa F; Grandes P; Bénard G; Marsicano G
Nature; 2016 Nov; 539(7630):555-559. PubMed ID: 27828947
[TBL] [Abstract][Full Text] [Related]
33. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
Bosier B; Hermans E; Lambert DM
Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715
[TBL] [Abstract][Full Text] [Related]
34. Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons.
Walwyn W; Evans CJ; Hales TG
J Neurosci; 2007 May; 27(19):5092-104. PubMed ID: 17494695
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid CB1 receptor elevation of intracellular calcium in neuroblastoma SH-SY5Y cells: interactions with muscarinic and delta-opioid receptors.
Marini P; Moriello AS; Cristino L; Palmery M; De Petrocellis L; Di Marzo V
Biochim Biophys Acta; 2009 Jul; 1793(7):1289-303. PubMed ID: 19445974
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB1 receptor-mediated inhibition of prolactin release and signaling mechanisms in GH4C1 cells.
Ho BY; Stadnicka A; Prather PL; Buckley AR; Current LL; Bosnjak ZJ; Kwok WM
Endocrinology; 2000 May; 141(5):1675-85. PubMed ID: 10803576
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
Álvaro-Bartolomé M; García-Sevilla JA
Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
[TBL] [Abstract][Full Text] [Related]
39. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.
Krishna Kumar K; Shalev-Benami M; Robertson MJ; Hu H; Banister SD; Hollingsworth SA; Latorraca NR; Kato HE; Hilger D; Maeda S; Weis WI; Farrens DL; Dror RO; Malhotra SV; Kobilka BK; Skiniotis G
Cell; 2019 Jan; 176(3):448-458.e12. PubMed ID: 30639101
[TBL] [Abstract][Full Text] [Related]
40. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
